SMI Expanded
1.647,52
PKT
+7,25
PKT
+0,44
%
Werbung
Analysen zu SMI Expanded-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.11.24 | Novartis Underweight | Barclays Capital | |
21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
21.11.24 | Novartis Buy | UBS AG | |
21.11.24 | Richemont Outperform | Bernstein Research | |
20.11.24 | Roche Hold | Jefferies & Company Inc. | |
20.11.24 | Novartis Hold | Deutsche Bank AG | |
20.11.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
20.11.24 | Nestlé Neutral | UBS AG | |
20.11.24 | Holcim Overweight | JP Morgan Chase & Co. | |
19.11.24 | Nestlé Outperform | RBC Capital Markets | |
19.11.24 | Richemont Overweight | JP Morgan Chase & Co. | |
19.11.24 | Roche Sell | Deutsche Bank AG | |
19.11.24 | Nestlé Outperform | RBC Capital Markets | |
19.11.24 | Nestlé Add | Baader Bank | |
19.11.24 | Nestlé Hold | Jefferies & Company Inc. | |
19.11.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
19.11.24 | Nestlé Neutral | UBS AG | |
19.11.24 | Nestlé Equal Weight | Barclays Capital | |
18.11.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
18.11.24 | Zurich Insurance Overweight | Barclays Capital | |
18.11.24 | Swiss Re Equal Weight | Barclays Capital | |
18.11.24 | Swiss Re Buy | UBS AG | |
18.11.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
18.11.24 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
18.11.24 | Swiss Re Sector Perform | RBC Capital Markets | |
15.11.24 | Givaudan Neutral | UBS AG | |
15.11.24 | Givaudan Underweight | Barclays Capital | |
15.11.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.11.24 | Nestlé Neutral | UBS AG | |
14.11.24 | Swiss Re Hold | Jefferies & Company Inc. | |
14.11.24 | Swiss Re Hold | Jefferies & Company Inc. | |
14.11.24 | Novartis Buy | UBS AG | |
14.11.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
14.11.24 | Givaudan Neutral | UBS AG | |
14.11.24 | Swiss Re Sector Perform | RBC Capital Markets | |
14.11.24 | Swiss Re Buy | UBS AG | |
14.11.24 | Nestlé Hold | Jefferies & Company Inc. | |
13.11.24 | Roche Neutral | UBS AG | |
12.11.24 | DocMorris Sell | UBS AG | |
12.11.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. |